Hosted on MSN17d
High Price of GLP-1 Agents Tip Cost-Benefit Scale Unfavorably
Despite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to an economic evaluation that compared four anti-obesity medications. Net ...
JSTOR Daily9mon
Fixed Cost, Variable Cost, Markups and Returns to Scale
https://doi.org/10.15609/annaeconstat2009.127.0061 • https://www.jstor.org/stable/10.15609/annaeconstat2009.127.0061 This paper derives the structure of a ...